<DOC>
	<DOCNO>NCT00004987</DOCNO>
	<brief_summary>The purpose study look safety effectiveness dextrin sulfate AIDS patient fail conventional anti-HIV treatment .</brief_summary>
	<brief_title>Treatment Advanced AIDS Patients With Dextrin Sulfate</brief_title>
	<detailed_description>Patients intraperitoneal ( IP ) catheter placement do study entry . Infusion carrier vehicle ( icodextrin 4 % ) begin 2 week later , 2 day , treatment dextrin sulphate ( DS ) commences . DS give three time per week . A nurse delivers initial treatment patient caregiver train give subsequent treatment DS give total 8 week . Patient evaluation do regularly treatment observation continue 24 week .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Inclusion Criteria Patients may eligible trial : Are HIVpositive . Have diagnose AIDS treatment prevent opportunistic ( AIDSrelated ) infection . Have CD4 cell count great 50 microL least past 3 month . Have viral load least 50,000 copies/ml least past 3 month . Have use treatment option . Are able understand give write consent . Exclusion Criteria Patients may eligible trial : Have study 6 week begin study . Have active , opportunistic infection infection . Have longterm medical condition nervous disorder might make difficult finish study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2001</verification_date>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Viral Load</keyword>
	<keyword>dextrin 2-sulfate</keyword>
	<keyword>Infusions , Parenteral</keyword>
</DOC>